Russia Claims New Ebola Strain Vaccine Developed

Russia. Amidst the growing risk of Ebola infection in Africa, Russia has claimed to have developed a vaccine that could be effective against a new strain of Ebola. According to the Russian Embassy in South Africa, the vaccine developed by Russian scientists has shown the possibility of providing protection even from the rare 'Bundibugyo' strain associated with the current outbreak.

The embassy stated that it has provided information that scientists have developed a vaccine against a new form of the Ebola virus, quoting Russian Health Minister Mikhail Murashko. It is claimed that this vaccine could also be useful against the Bundibugyo strain, especially related to the outbreak seen in the Congo region.

Russia has announced the development of a vaccine against a new Ebola strain at a time when the Ebola outbreak spreading in Central Africa is increasing the concerns of international health organizations. Under the International Health Regulations (IHR) 2005, the World Health Organization (WHO) classified the situation as a 'Public Health Emergency of International Concern' (PHEIC) on May 17, taking into account the Ebola outbreaks seen in the Democratic Republic of Congo (DRC) and Uganda.

According to a press release issued by the Ministry of Health and Family Welfare, the Africa Centers for Disease Control and Prevention (Africa CDC) has also formally confirmed the outbreak of Ebola virus disease related to the Bundibugyo strain spreading in Congo and Uganda.

Meanwhile, the WHO's IHR Emergency Committee released interim recommendations on May 22, suggesting further precautionary measures. The committee has urged to further strengthen disease surveillance systems at international entry points for the identification, assessment, reporting, and management of travelers with unexplained fever coming from areas where the Bundibugyo virus has been confirmed. It has also been recommended not to travel unnecessarily to areas where the virus has been detected.

According to the press release, the risk of the disease spreading is assessed to be high in areas bordering the Democratic Republic of Congo and Uganda, especially in regions like South Sudan.

Ebola disease is a very serious viral hemorrhagic fever. It is caused by infection with the Bundibugyo strain of the Ebola virus. This disease is considered to be associated with high mortality. So far, no vaccine or specific treatment has received formal approval for the prevention or treatment of Ebola disease caused by the Bundibugyo strain. In this context, the claim of new vaccine development by Russia is being watched with interest by the international health community.